These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7682466)

  • 1. Antibody and T cell responses to measles virus polypeptides and synthetic peptides.
    Mäkelä MJ; Ilonen J; Salmi AA
    FEMS Immunol Med Microbiol; 1993 Jan; 6(1):3-11. PubMed ID: 7682466
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
    Olszewska W; Obeid OE; Steward MW
    Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen.
    Cardoso AI; Sixt N; Vallier A; Fayolle J; Buckland R; Wild TF
    J Virol; 1998 Mar; 72(3):2516-8. PubMed ID: 9499116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children.
    Jaye A; Magnusen AF; Sadiq AD; Corrah T; Whittle HC
    J Clin Invest; 1998 Dec; 102(11):1969-77. PubMed ID: 9835622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
    Partidos CD; Vohra P; Steward MW
    Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
    Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
    Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental measles. II. Infection and immunity in the rhesus macaque.
    Zhu YD; Heath J; Collins J; Greene T; Antipa L; Rota P; Bellini W; McChesney M
    Virology; 1997 Jun; 233(1):85-92. PubMed ID: 9229928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of measles.
    Lancet; 1989 Sep; 2(8666):780-1. PubMed ID: 2571016
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.
    El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP
    J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
    Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD
    Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
    Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
    Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally.
    Hathaway LJ; Partidos CD; Vohra P; Steward MW
    Vaccine; 1995 Nov; 13(16):1495-500. PubMed ID: 8578832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes.
    Lorin C; Delebecque F; Labrousse V; Da Silva L; Lemonnier F; Brahic M; Tangy F
    Vaccine; 2005 Aug; 23(36):4463-72. PubMed ID: 15993518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis.
    Brinckmann UG; Bankamp B; Reich A; ter Meulen V; Liebert UG
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2491-500. PubMed ID: 1833505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of measles virus antigens in Streptococcus gordonii.
    Maggi T; Oggioni MR; Medaglini D; Bianchi Bandinelli ML; Soldateschi D; Wiesmüller KH; Muller CP; Valensin PE; Pozzi G
    New Microbiol; 2000 Apr; 23(2):119-28. PubMed ID: 10872681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy.
    Bouche FB; Steinmetz A; Yanagi Y; Muller CP
    Vaccine; 2005 Mar; 23(17-18):2074-7. PubMed ID: 15755573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.
    Partidos CD; Obeid OE; Steward MW
    Immunology; 1992 Oct; 77(2):262-6. PubMed ID: 1385315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype-specific and canine distemper virus cross-reactive H-2Kk-restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein.
    Beauverger P; Chadwick J; Buckland R; Wild TF
    Virology; 1994 Aug; 203(1):172-7. PubMed ID: 7518168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immune competent mouse model for the characterization of recombinant measles vaccines.
    Marty RR; Knuchel MC; Morin TN; Naim HY
    Hum Vaccin Immunother; 2015; 11(1):83-90. PubMed ID: 25483519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte responses against measles virus.
    UytdeHaag FG; van Binnendijk RS; Kenter MJ; Osterhaus AD
    Curr Top Microbiol Immunol; 1994; 189():151-67. PubMed ID: 7924435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.